• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

70岁及以上肝硬化患者经颈静脉肝内门体分流术后的结局

Outcomes After Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients 70 Years and Older.

作者信息

Adlakha Natasha, Russo Mark W

机构信息

Division of Gastroenterology, Atrium Health-Carolinas Medical Center, Charlotte, NC 28203, USA.

Division of Hepatology, Atrium Health-Carolinas Medical Center, Charlotte, NC 28203, USA.

出版信息

J Clin Med. 2020 Jan 31;9(2):381. doi: 10.3390/jcm9020381.

DOI:10.3390/jcm9020381
PMID:32023959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7073642/
Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) is effective at treating ascites and variceal bleeding but may be associated with increased morbidity and mortality in older patients. Our aim was to report outcomes in patients 70 years and older who underwent TIPS because data are limited in this population. We performed a retrospective review of patients who underwent TIPS at our institution over 10 years. We matched those 70 years and older to those 50-59 years old by year of TIPS and the Model for End-Stage Liver Diseae-Sodium (MELD-Na). Thirty-day readmissions were higher in the elderly group ( = 50) compared to the younger group ( = 50), = 17 (34%) and = 6 (12%) ( = 0.02), respectively. Readmissions for post-TIPS hepatic encephalopathy (HE) in the older and younger groups were = 14 (28%) and = 5 (10%) ( = 0.04), respectively. Thirty-day mortality was higher in the older group compared to the younger group, but the difference was not statistically significant, 24% and 12%, respectively ( = 0.19). TIPS can be performed safely in patients 70 years and older, but the overall readmissions, and specifically for HE, were significantly higher in older patients. Patients 70 years and older should be followed closely after TIPS, and early introduction of treatment for encephalopathy should be considered.

摘要

经颈静脉肝内门体分流术(TIPS)在治疗腹水和静脉曲张出血方面有效,但可能会增加老年患者的发病率和死亡率。我们的目的是报告70岁及以上接受TIPS治疗患者的预后情况,因为该人群的数据有限。我们对在我们机构10年间接受TIPS治疗的患者进行了回顾性研究。我们根据TIPS年份和终末期肝病-钠模型(MELD-Na)将70岁及以上的患者与50-59岁的患者进行匹配。老年组(n = 50)的30天再入院率高于年轻组(n = 50),分别为17例(34%)和6例(12%)(P = 0.02)。老年组和年轻组TIPS后肝性脑病(HE)的再入院率分别为14例(28%)和5例(10%)(P = 0.04)。老年组的30天死亡率高于年轻组,但差异无统计学意义,分别为24%和12%(P = 0.19)。70岁及以上的患者可以安全地进行TIPS,但老年患者的总体再入院率,尤其是HE的再入院率明显更高。70岁及以上的患者在TIPS后应密切随访,并应考虑尽早引入脑病治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a091/7073642/29bcaa2afc4d/jcm-09-00381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a091/7073642/29bcaa2afc4d/jcm-09-00381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a091/7073642/29bcaa2afc4d/jcm-09-00381-g001.jpg

相似文献

1
Outcomes After Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients 70 Years and Older.70岁及以上肝硬化患者经颈静脉肝内门体分流术后的结局
J Clin Med. 2020 Jan 31;9(2):381. doi: 10.3390/jcm9020381.
2
Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.经颈静脉肝内门体分流术时经皮穿刺左支门静脉以减少肝性脑病。
World J Gastroenterol. 2019 Mar 7;25(9):1088-1099. doi: 10.3748/wjg.v25.i9.1088.
3
Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.8 毫米覆膜 TIPS 并不影响分流功能,但可降低预防静脉曲张再出血的肝性脑病发生率。
J Hepatol. 2017 Sep;67(3):508-516. doi: 10.1016/j.jhep.2017.05.006. Epub 2017 May 12.
4
Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm.使用膨体聚四氟乙烯覆膜支架型人工血管建立经颈静脉肝内门体分流术的临床疗效:8毫米与10毫米对比
Cardiovasc Intervent Radiol. 2019 May;42(5):737-743. doi: 10.1007/s00270-019-02162-4. Epub 2019 Jan 14.
5
Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.逐步扩张经颈静脉肝内门体分流术:单中心经验。
AJR Am J Roentgenol. 2018 Feb;210(2):438-446. doi: 10.2214/AJR.17.18222. Epub 2017 Dec 20.
6
Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.经颈静脉肝内门体分流术的长期影响及并发症:单中心经验
Scand J Gastroenterol. 2019 Jul;54(7):899-904. doi: 10.1080/00365521.2019.1630675. Epub 2019 Jun 16.
7
Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.经颈静脉肝内门体分流术治疗后病毒性肝炎相关肝硬化患者的长期临床结局。
Virol J. 2018 Oct 1;15(1):151. doi: 10.1186/s12985-018-1067-7.
8
Does advanced chronic kidney disease impact transjugular intrahepatic portosystemic shunt efficacy and safety?晚期慢性肾脏病会影响经颈静脉肝内门体分流术的疗效和安全性吗?
Acta Gastroenterol Belg. 2017 Apr-Jun;80(2):243-248.
9
Comparison of Transjugular Intrahepatic Portosystemic Shunt with Covered Stent and Balloon-Occluded Retrograde Transvenous Obliteration in Managing Isolated Gastric Varices.经颈静脉肝内门体分流术联合覆膜支架与球囊闭塞逆行静脉栓塞术治疗孤立性胃静脉曲张的比较
Korean J Radiol. 2017 Mar-Apr;18(2):345-354. doi: 10.3348/kjr.2017.18.2.345. Epub 2017 Feb 7.
10
Transjugular intrahepatic portosystemic shunt treatment of variceal bleeding in an unselected patient population.经颈静脉肝内门体分流术治疗未选择患者群体的静脉曲张出血。
Scand J Gastroenterol. 2018 Jan;53(1):70-75. doi: 10.1080/00365521.2017.1386795. Epub 2017 Oct 9.

引用本文的文献

1
Association Between Older Age and TIPS-Related Hospitalization Following Shunt Placement.年龄较大与分流术后TIPS相关住院之间的关联。
Can J Gastroenterol Hepatol. 2025 May 21;2025:8894058. doi: 10.1155/cjgh/8894058. eCollection 2025.
2
Utility of Advanced Age as a Predictor of Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt.高龄作为经颈静脉肝内门体分流术患者预后预测指标的效用
Dig Dis Sci. 2025 Mar 1. doi: 10.1007/s10620-025-08940-0.
3
Management of Portal Hypertension in the Older Patient.老年患者门静脉高压症的处理。

本文引用的文献

1
Older age is associated with increased early mortality after transjugular intrahepatic portosystemic shunt.年龄较大与经颈静脉肝内门体分流术后早期死亡率增加有关。
Ann Hepatol. 2016 Mar-Apr;15(2):215-221. doi: 10.5604/16652681.1193716.
2
OPTN/SRTR 2017 Annual Data Report: Liver.OPTN/SRTR 2017 年度数据报告:肝脏。
Am J Transplant. 2019 Feb;19 Suppl 2:184-283. doi: 10.1111/ajt.15276.
3
Short outcome comparison of elderly patients versus nonelderly patients treated with transjugular intrahepatic portosystemic stent shunt: A propensity score matched cohort study.
Curr Gastroenterol Rep. 2024 Sep;26(9):231-240. doi: 10.1007/s11894-024-00930-y. Epub 2024 May 23.
4
Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy-A Review of the Past Decade's Literature Focusing on Incidence, Risk Factors, and Prophylaxis.经颈静脉肝内门体分流术(TIPS)相关性肝性脑病——基于发病率、危险因素及预防的过去十年文献综述
J Clin Med. 2023 Dec 19;13(1):14. doi: 10.3390/jcm13010014.
5
Chronic Liver Disease in the Older Patient-Evaluation and Management.老年患者的慢性肝病——评估与管理。
Curr Gastroenterol Rep. 2023 Dec;25(12):390-400. doi: 10.1007/s11894-023-00908-2. Epub 2023 Nov 22.
6
Transjugular Intrahepatic Portosystemic Shunt Outcomes in the Elderly Population: A Systematic Review and Meta-Analysis.老年人群经颈静脉肝内门体分流术的结局:一项系统评价和荟萃分析
Gastroenterology Res. 2022 Dec;15(6):325-333. doi: 10.14740/gr1571. Epub 2022 Dec 1.
7
Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.肝硬化患者经颈静脉肝内门体分流术:详尽的批判性更新。
World J Gastroenterol. 2020 Oct 7;26(37):5561-5596. doi: 10.3748/wjg.v26.i37.5561.
经颈静脉肝内门体分流术治疗老年患者与非老年患者的短期疗效比较:一项倾向评分匹配队列研究。
Medicine (Baltimore). 2017 Jul;96(29):e7551. doi: 10.1097/MD.0000000000007551.
4
Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.肝硬化门静脉高压出血:风险分层、诊断及管理:美国肝病研究协会2016年实践指南
Hepatology. 2017 Jan;65(1):310-335. doi: 10.1002/hep.28906. Epub 2016 Dec 1.
5
Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt.83884例经颈静脉肝内门体分流术患者住院死亡率的全国趋势及预测因素
World J Gastroenterol. 2016 Jul 7;22(25):5780-9. doi: 10.3748/wjg.v22.i25.5780.
6
Age-related Morbidity and Mortality After Transjugular Intrahepatic Portosystemic Shunts.经颈静脉肝内门体分流术后与年龄相关的发病率和死亡率
J Clin Gastroenterol. 2017 Apr;51(4):360-363. doi: 10.1097/MCG.0000000000000541.
7
Clearing the Confusion over Hepatic Encephalopathy After TIPS Creation: Incidence, Prognostic Factors, and Clinical Outcomes.消除经颈静脉肝内门体分流术(TIPS)术后肝性脑病的困惑:发病率、预后因素及临床结局
Dig Dis Sci. 2015 Apr;60(4):1059-66. doi: 10.1007/s10620-014-3391-0. Epub 2014 Oct 15.
8
Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.经颈静脉肝内门体分流术治疗肝硬化难治性腹水患者的长期临床结局
J Gastroenterol Hepatol. 2015 Feb;30(2):389-95. doi: 10.1111/jgh.12725.
9
Older patient age may predict early mortality after transjugular intrahepatic portosystemic shunt creation in individuals at intermediate risk.老年患者年龄可能预示着中危个体经颈静脉肝内门体分流术治疗后的早期死亡率。
J Vasc Interv Radiol. 2013 Jul;24(7):941-6. doi: 10.1016/j.jvir.2013.03.018. Epub 2013 May 23.
10
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with recurrent variceal hemorrhage.经颈静脉肝内门体分流术治疗复发性食管胃静脉曲张出血后肝性脑病。
Gastroenterol Res Pract. 2013;2013:398172. doi: 10.1155/2013/398172. Epub 2013 Mar 28.